Phagocytic Activity in Type 2 Diabetes
Author Information
Author(s): Lecube Albert, Pachón Gisela, Petriz Jordi, Hernández Cristina, Simó Rafael
Primary Institution: Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
Hypothesis
Is phagocytic activity impaired in type 2 diabetic patients and can it be improved with better glycemic control?
Conclusion
Improving glycemic control in type 2 diabetes can enhance phagocytic activity.
Supporting Evidence
- Type 2 diabetic patients showed a lower percentage of activated macrophages compared to non-diabetic subjects.
- Significant negative correlations were found between phagocytic activity and fasting glucose and HbA1c.
- Improvement in phagocytic activity was observed in 9 out of 12 patients after blood glucose optimization.
Takeaway
People with type 2 diabetes have trouble fighting infections, but getting their blood sugar under control can help them fight better.
Methodology
A case-control study comparing phagocytic activity between 21 type 2 diabetic patients and 21 healthy volunteers, with a subset undergoing a 5-day blood glucose optimization treatment.
Potential Biases
Potential selection bias in recruiting participants and the short duration of the intervention.
Limitations
The study's findings may not be generalizable to all diabetic patients due to the specific population studied.
Participant Demographics
21 type 2 diabetic patients and 21 healthy volunteers, matched by age, gender, and BMI.
Statistical Information
P-Value
p=0.006
Confidence Interval
95% CI −24.64 to −4.41
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website